- Previous Close
104.71 - Open
105.06 - Bid 104.56 x 800
- Ask 104.60 x 800
- Day's Range
104.24 - 105.23 - 52 Week Range
75.08 - 115.50 - Volume
482,842 - Avg. Volume
2,226,942 - Market Cap (intraday)
57.942B - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
15.50 - EPS (TTM)
6.73 - Earnings Date Jan 29, 2025 - Feb 3, 2025
- Forward Dividend & Yield 2.00 (1.91%)
- Ex-Dividend Date Nov 20, 2024
- 1y Target Est
103.77
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
www.aflac.com12,785
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AFL
View More
Performance Overview: AFL
Trailing total returns as of 11/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFL
View MoreValuation Measures
Market Cap
58.17B
Enterprise Value
64.77B
Trailing P/E
15.56
Forward P/E
14.90
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.44
Price/Book (mrq)
2.34
Enterprise Value/Revenue
3.72
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
22.01%
Return on Assets (ttm)
2.35%
Return on Equity (ttm)
16.04%
Revenue (ttm)
17.3B
Net Income Avi to Common (ttm)
3.81B
Diluted EPS (ttm)
6.73
Balance Sheet and Cash Flow
Total Cash (mrq)
9.16B
Total Debt/Equity (mrq)
49.28%
Levered Free Cash Flow (ttm)
2.87B
Research Analysis: AFL
View MoreCompany Insights: AFL
AFL does not have Company Insights
Research Reports: AFL
View MoreLowering target price to $121.00
AFLAC INC has an Investment Rating of BUY; a target price of $121.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $123.00
AFLAC INC has an Investment Rating of BUY; a target price of $123.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetRaising target price to $125.00
AFLAC INC has an Investment Rating of BUY; a target price of $125.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $123.00
AFLAC INC has an Investment Rating of BUY; a target price of $123.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice Target